1. Home
  2. EVC vs ALDX Comparison

EVC vs ALDX Comparison

Compare EVC & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$2.99

Market Cap

273.8M

Sector

Industrials

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.14

Market Cap

317.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
ALDX
Founded
1996
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.8M
317.7M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
EVC
ALDX
Price
$2.99
$4.14
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
349.6K
1.0M
Earning Date
06-10-2026
01-01-0001
Dividend Yield
6.60%
N/A
EPS Growth
47.59
40.43
EPS
N/A
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$123.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$1.18
52 Week High
$3.68
$6.99

Technical Indicators

Market Signals
Indicator
EVC
ALDX
Relative Strength Index (RSI) 47.20 34.77
Support Level $2.85 $2.60
Resistance Level $3.17 $5.70
Average True Range (ATR) 0.16 0.43
MACD -0.01 -0.10
Stochastic Oscillator 13.66 6.36

Price Performance

Historical Comparison
EVC
ALDX

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: